AI Article Synopsis

  • The study aimed to evaluate how well amphotericin B (AMPH-B) penetrates the eyes after intravenous administration of liposomal amphotericin B (L-AMB) in patients with fungal eye infections.
  • Seven eyes from five patients were treated with varying doses of L-AMB, and samples were taken from various eye fluids and blood to measure AMPH-B levels.
  • Results showed high concentrations of AMPH-B in the cornea of the keratitis case, but much lower levels were found in the aqueous and vitreous humors, suggesting that L-AMB may only be effective for mild cases of fungal endophthalmitis.

Article Abstract

Purpose: To determine the intraocular penetration of amphotericin B (AMPH-B) after an intravenously injection of liposomal amphotericin B (L-AMB) in inflamed human eyes.

Methods: Seven eyes of 5 patients with fungal eye diseases (endophthalmitis in 6 eyes and keratitis in 1 eye) were treated with intravenous injections of 100-250 mg/day of L-AMB. Samples of blood, corneal button, aqueous humor, and vitreous humor were collected and assessed for AMPH-B.

Results: The AMPH-B level in the cornea (604.0 μg/g) of the case with fungal keratitis exceeded the minimum inhibitory concentration. However, the levels in the aqueous and vitreous humors of the cases with fungal endophthalmitis were lower, e.g., 0.02 ± 0.01 μg/ml (0.09% of serum level) in the aqueous humor and 0.05 ± 0.08 μg/ml (0.17% of serum level) in the vitreous humor.

Conclusions: The AMPH-B levels administered intravenously were very low in the aqueous and vitreous humors. Our findings indicate that intravenous L-AMB can be considered only for patients with mild endogenous fungal endophthalmitis, e.g., isolated chorioretinitis without vitreous extensions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jiac.2021.04.020DOI Listing

Publication Analysis

Top Keywords

intraocular penetration
8
liposomal amphotericin
8
inflamed human
8
aqueous humor
8
aqueous vitreous
8
vitreous humors
8
fungal endophthalmitis
8
serum level
8
vitreous
5
penetration liposomal
4

Similar Publications

[Not Available].

Tunis Med

January 2025

Department of Ophthalmology, Habib Bourguiba Hospital, Sfax Faculty of Medicine, University of Sfax, Tunisia.

Introduction: Work-related open-globe injuries are a major cause of preventable vision loss worldwide with a significant socioeconomic impact.

Aim: To describe the demographics and clinical characteristics, identify the prognostic factors of work-related open-globe injuries and suggest preventive measures to minimize the incidence of these accidents.

Methods: A retrospective study of patients hospitalized in the Ophthalmology Department of Habib Bourguiba University Hospital, Sfax, Tunisia, for occupational open-globe injuries, between January 2020 and December 2022.

View Article and Find Full Text PDF

Animal models that help us understand how elevated intraocular pressure (IOP) causes axonal injury will lead to new glaucoma therapies. Because reliable measurements are difficult to obtain in chronic models, we developed the controlled elevation of IOP (CEI) approach. Here, a cannula connected to an elevated balanced salt solution (BSS) reservoir is inserted into the anterior chamber of anesthetized Brown Norway rats.

View Article and Find Full Text PDF

Enhanced Ocular Bioavailability and Prolonged Duration via Hydrophilic Surface Nanocomposite Vesicles for Topical Drug Administration.

Pharmaceutics

November 2024

Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Center of Topical Precise Drug Delivery System, Guangdong Pharmaceutical University, No. 280 University Town Outer Ring East Road, Guangzhou 510006, China.

Background: Internal ocular diseases, such as macular edema, uveitis, and diabetic macular edema require precise delivery of therapeutic agents to specific regions within the eye. However, the eye's complex anatomical structure and physiological barriers present significant challenges to drug penetration and distribution. Traditional eye drops suffer from low bioavailability primarily due to rapid clearance mechanisms.

View Article and Find Full Text PDF

A water-soluble drug nanoparticle-loaded in situ gel for enhanced precorneal retention and its transduction mechanism of pharmacodynamic effects.

Int J Pharm

December 2024

Guangdong Provincial Key Laboratory for Research and Evaluation of Pharmaceutical Preparations, College of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, PR China. Electronic address:

Article Synopsis
  • Timolol maleate (TM) is commonly used to treat glaucoma, but traditional eye drops don't work well due to the eye's barriers.
  • Researchers created a new formulation using nanoparticles (NPs) and an in situ gel (ISG) system to improve drug delivery and retention.
  • The new formulation showed excellent safety, longer duration in the eye, and effectively lowered intraocular pressure for up to 12 hours, providing insights for future glaucoma treatments.
View Article and Find Full Text PDF

We present the case of a patient who came to the emergency department with a significant decrease in vision and dilated pupil in the left eye. Since neurological pathologies were primarily considered, diffusion brain magnetic resonance imaging (MRI) and brain computed tomography (CT) were requested. After the results were reported as normal, we were consulted.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!